AstraZeneca

Making NF1 better understood

For the NF1 awareness day in Casablanca, we supported AstraZeneca and the Moroccan Neurofibromatosis Association with press coordination, bilingual material and an awareness podcast, followed by media coverage of the issues raised.

Where
Casablanca, Morocco
When
May–June 2026
Our role
Media relations & awareness content
With AstraZeneca and AMNF

Our role

We supported the event’s media coordination and bilingual communication, alongside photography, video and an awareness podcast.

Explore the outcome

A longer conversation

The awareness podcast with Maha Chraibi and AMNF’s president.

Maha Chraibi · Podcast Santé MarocWatch on YouTube

Press + broadcast

Coverage of the issues raised

Written reporting alongside television and radio coverage.

Awareness podcast

A longer-form discussion

A programme with Maha Chraibi and expert and association voices.

The situation

On 17 May 2026, AstraZeneca and the Moroccan Neurofibromatosis Association brought patients, families and health professionals together in Casablanca. The discussion concerned recognition of neurofibromatosis as a chronic condition and more equitable access to care.

We supported the communication around the event. Our remit included press invitations and on-site media coordination, French and Arabic press material, photography and video, and an awareness podcast. The subject needed explanation for people outside a specialist medical audience, while keeping the association’s concerns visible.

The guiding idea

Explain the issue through both press reporting and a longer conversation.

The approach

The programme used different formats to explain the same subject. Written press material set out the event and the call for recognition. A podcast with Maha Chraibi and expert and association voices allowed more time for discussion than a short announcement.

We coordinated that content with the event’s press activity. The release went through AstraZeneca and association approval before distribution. This kept the public information tied to the organisations involved, while journalists could choose how to address the issue for their own audiences.

The work

We handled invitations and media coordination on site, prepared French and Arabic releases and followed their publication. Photography, video and the awareness podcast formed part of the delivered programme.

We also pitched the subject to broadcast media and followed the published reporting. The media debrief brought together press coverage and podcast reporting, giving the client a view of how the subject had appeared across the different formats.

What we delivered

Bilingual press materials

French and Arabic releases with client and association approval.

Event media support

Invitations, on-site coordination and coverage follow-up.

Awareness content

Photography, video and podcast production.

Headline and opening paragraph from the French release about neurofibromatosis awareness.Enlarge excerpt
Approved press-release excerpt · May 2026AstraZeneca / AMNF

The issue presented to the press

The client-approved release sets out AMNF’s call for better recognition of neurofibromatosis and more equitable access to care. The excerpt shows the headline and opening paragraph of the distributed document.

View the publication

The outcome

The story appeared in written, podcast and broadcast formats. Le360’s article on 19 May explained the association’s call for recognition as a long-term condition and the difficulties families faced in accessing care. The delivered reporting also documented television and radio coverage alongside the awareness content.

These outputs extended the discussion beyond the people attending the event. The written reporting set out the association’s concerns, while the longer-form awareness content gave expert and association voices more time to explain the subject. Our work connected that content with press outreach and follow-up.

The story in public.

Selected reporting and announcements from the project.

Continue exploring.

A regional conversation about women’s health